CD40LG and COVID-19: Heinz et al. [43] found platelet aggregability to be unchanged in COVID-19 patients in response to TRAP or arachidonic acid but to be reduced by ADP treatment compared to healthy subjects; however, they conclude that it is not possible to generalize on platelet function in COVID-19 [43].